Benefits
Strength and lean body mass gains
A 12-week double-blind RCT in resistance-trained men demonstrated PEAK ATP® (400 mg/day) combined with resistance training significantly increased muscle thickness, lean body mass, and total body strength vs. placebo + training. A meta-analysis of 5 RCTs confirmed significant improvements in maximal strength with ATP supplementation vs. placebo, particularly in resistance-trained men.
Fatigue resistance and endurance maintenance
Acute PEAK ATP® supplementation (400 mg) significantly improved maintenance of peak force output during repeated high-intensity sets — reducing fatigue rate and preserving peak torque in later sets of exhaustive exercise. This anti-fatigue mechanism is distinct from energy production support (creatine) and works through improved blood flow and reduced muscle fatigue signaling.
Blood flow and muscle vasodilation
Extracellular ATP activates P2Y purinergic receptors on endothelial cells, triggering nitric oxide and prostaglandin release that drives vasodilation in active muscle. This blood flow enhancement improves oxygen and nutrient delivery to working muscle — complementary to NO-boosting ingredients like L-citrulline but through a completely different mechanism.
Amino acid absorption enhancement
New 2025 research confirms oral PEAK ATP® significantly enhances amino acid bioavailability following protein consumption in both younger and older adults. ATP's role in intestinal amino acid transport (stimulating P2Y receptors on enterocytes to enhance amino acid uptake) creates a novel application as a protein-potentiating ingredient in protein powders and recovery formulas.
Mechanism of action
Extracellular purinergic receptor signaling
Orally consumed ATP is not primarily absorbed intact into circulation — instead, it acts as an extracellular signaling molecule in the gut and vasculature by activating P2X and P2Y purinergic receptors on intestinal epithelium, endothelial cells, and red blood cells. P2Y receptor activation triggers NO-mediated vasodilation, P2X activation enhances muscle calcium release for stronger contractions, and intestinal P2Y signaling enhances amino acid transporter activity. This extracellular signaling mechanism explains ATP's efficacy despite limited systemic absorption.
Clinical trials
Randomized, double-blind, placebo-controlled trial of PEAK ATP® (400 mg/day disodium ATP) + resistance training vs placebo + training in 21 resistance-trained men for 12 weeks. (Wilson et al. 2013, Nutr Metab)
21 resistance-trained men. 12-week intervention.
PEAK ATP® increased quad muscle thickness (~+1.7 cm), lean body mass (~+1.7 kg), vertical jump power (~+30%), 1RM strength vs placebo. CRITICAL CAVEAT: striking effect sizes for a 12-week RT trial; small sample (n=21); industry-funded (TSI Group). Effect sizes vastly exceed typical resistance training adaptations — warrants independent replication. The mechanism (oral ATP supplementation increasing extracellular ATP without raising intracellular muscle ATP) is biologically debated.
Systematic review and meta-analysis of 5 human clinical studies (2000-2022) on oral ATP supplementation effects on strength and power performance.
Pooled across 5 ATP studies.
ATP supplementation modestly improved maximal strength vs placebo. Effect size modest. CRITICAL CAVEAT: limited number of independent trials; substantial industry funding across the literature. Generally underwhelming evidence relative to creatine (which has hundreds of trials and Cochrane-level evidence).